Defective thrombin-induced calcium changes and aggregation of Bernard-Soulier platelets are not associated with deficient moderate-affinity receptors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 5, 1996, Pages 628-632

  McNicol, A ^a   Sutherland, M ^b   Zou, R ^b   Drouin, J ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bernard Soulier syndrome; calcium; platelets; thrombin; TRAP

Indexed keywords

CALCIUM ION; GLYCOPROTEIN IB; THROMBIN RECEPTOR;

ARTICLE; BERNARD SOULIER DISEASE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOSOL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029897983     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.5.628     Document Type: Article

References (42)

1. McNicol A, Gerrard JM. Post receptor events associated with thrombin-induced platelet activation. Blood Coagul Fibrinolysis. 1993;4:975-991.
2. Vu TH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
3. 2+ mobilization. FEBS Lett. 1991;288:123-128.
4. Brass LF, Vassallo RR, Belmonte E, Ahuja M, Cichowski K, Hoxie JA. Structure and function of the human platelet thrombin receptor. J Biol Chem. 1992;267:13795-13798.
5. Coughlin SR. Thrombin receptor structure and function. Thromb Haemost. 1993;70:184-187.
6. Huang R, Sorisky A, Church WR, Simons ER, Rittenhouse SE. Thrombin receptor-directed ligands account for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J Biol Chem. 1991;266:18435-18438.
7. Seiler SM, Goldenberg HJ, Michel IM, Hunt JT, Zavoico GB. Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor. Biochem Biophys Res Commun. 1991;181:636-643.
8. Kinlough-Rathbone RL, Perry DW, Guccione MA, Rand ML, Packham MA. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb Haemost. 1993;70:1019-1023.
9. Pumiglia KM, Feinstein MB. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Biochem J. 1993;294:253-260.
10. Lau L-F, Pumiglia K, Côté YP, Feinstein MB. Thrombin receptor activating peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary messengers. Biochem J. 1994;303:391-400.
11. Greco NJ, Jamieson GA. High and moderate affinity pathways for alpha-thrombin-induced platelet activation. Proc Soc Exp Biol Med. 1991;198:792-799.
12. Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton JW, Krutzsch H. High affinity α-thrombin binding to platelet glycoprotein Ibα: identification of two binding domains. Proc Natl Acad Sci USA. 1994;91:6334-6338.
13. Yamamoto N, Greco NJ, Barnard MR, Tanoue K, Yamazaki H, Jamieson GA, Michclson AD. Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood. 1991;77:1740-1748.
14. De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM. Function of glycoprotein Ibα in platelet activation induced by αthrombin. J Biol Chem. 1991;266:23776-23783.
15. Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire-hémorragipare congénitale. Semaine des Hôpitaux de Paris. 1948;24:3217-3223.
16. Nurden A, Caen JP. Specific role for platelet surface glycoproteins in platelet function. Nature. 1975;255:720-722.
17. Clemetson KJ, McGregor JL, James E, Dechavanne M, Lüscher EF. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest. 1982;70:304-311.
18. Berndt MC, Gregory C, Chong BH, Zola H, Castaldi PA. Additional glycoprotein defects in Bernard-Soulier syndrome: confirmation of genetic basis by parental analysis. Blood. 1983;62:800-807.
19. Drouin J, McGregor JL, Parmentier S, Izaguirre CA, Clemetson KJ. Residual amounts of glycoprotein Ib concomitant with near-absence of glycoprotein IX in platelets of Bernard-Soulier patients. Blood. 1988;72:1086-1088.
20. Drouin J, Sutherland M, McLeish WA, Cantin G, McGregor JL, Jobin F. Bernard-Soulier syndrome in three Canadian families: clinical and laboratory observations. Platelets. 1992;3:311-316.
21. Arai M, Yamamoto N, Akamatsu N, Suzuki H, Yamaguchi A, Nishida Y, Fukutake K, Tanoue K. Substantial expression of glycoproteins IX and V on the platelet surface from a patient with Bernard-Soulier syndrome. Br J Haematol. 1994;87:185-188.
22. Jamieson GA, Okamura T. Reduced thrombin binding and aggregation in Bernard-Soulier platelets. J Clin Invest. 1978;61:861-864.
23. Berndt MC, Du X, Booth WJ. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 1988;27:633-641.
24. Jandrot-Perrus M, Rendu F, Caen JP, Levy-Toledano S, Guillin M-C. The common pathway for alpha- and gamma-thrombin-induced platelet activation is independent of GPIb: a study of Bernard-Soulier platelets. Br J Haematol. 1990;75:385-392.
25. McNicol A, Drouin J, Clemetson KJ, Gerrard JM. Phospholipase C activity in platelets from Bernard-Soulier syndrome patients. Arterioscler Thromb. 1993;13:1567-1571.
26. Gralnick HR, Williams S, McKeown L, Hansmann K, Vail M, Krutzsch H. The presence and function of the seven transmembrane thrombin receptors of Bernard-Soulier platelets. Blood. 1992;80:1051. Abstract.
27. McNicol A, Saxena SP, Becker AB, Brandes LJ, Gerrard JM. Further studies on the effects of the intracellular histamine antagonist DPPE on platelet function. Platelets. 1991;2:215-221.
28. 3H]-arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycon and collagen. Biochem J. 1986; 235:869-877.
29. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993;268:13756-13763.
30. Coller BS, Zanabi MH. Platelet membrane studies in the May-Hegglin anomaly. Blood. 1981;58:279-284.
31. McNicol A, Gerrard JM, MacIntyre DE. Evidence for two mechanisms of thrombin-induced platelet activation: one proteolytic, one receptor mediated. Biochem Cell Biol. 1989;67:332-336.
32. Sindt KA, Hewlett EL, Redpath GT, Rappuoli R, Gray LS, Vandenberg SR. Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib. Infect Immun. 1994;62:3108-3114.
33. Brass LF, Hoxie JA, Kieber-Emmons T, Manning DR, Poncz M, Woolkalis M. Agonist receptors and G-proteins as mediators of platelet activation. In: Authi KS, Watson SP, Kakkar VV, eds. Mechanisms of Platelet Activation and Control. New York, NY: Plenum Press; 1993:17-36.
34. Okamura T, Hasitz M, Jamieson GA. Platelet glycocalicin: interaction with thrombin and role as thrombin receptor of platelet surface. J Biol Chem. 1978;253:3435-3443.
35. Harmon JT, Jamieson GA. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. J Biol Chem. 1986;261:13224-13229.
36. Harmon JT, Jamieson GA. Platelet activation by thrombin in the absence of a high affinity receptor. Biochemistry. 1988;27:2151-2157.
37. Yamamoto K, Yamamoto N, Kitagawa H, Tanoue K, Kosaki G, Yamazaki H. Localization of thrombin-binding site on human platelet glycoprotein Ib determined by monoclonal antibody. Thromb Haemost. 1986;55:162-167.
38. Jandrot-Perrus M, Didry D, Guillin MC, Nurden AT. Cross linking of alpha- and gamma-thrombin to distinct binding sites on human platelets. Eur J Biochem. 1988;174:359-367.
39. Alexander RJ, Fenton JW, Detwiler TC. Thrombin-platelet interactions: an assessment of the roles of saturable and nonsaturable binding in platelet activation. Arch Biochem Biophys. 1983;222: 266-275.
40. Wicki AW, Clemetson KJ. Structure and function of platelet membrane glycoproteins Ib and V. Eur J Biochem. 1985;153:1-11.
41. McGowan EB, Detwiler TC. Modified platelet responses to thrombin: evidence for two types of receptors or coupling mechanisms. J Biol Chem. 1986;261:739-746.
42. Kramer RM, Roberts EF, Hyslop PA, Utterback BG, Hui KY, Jakubowski JA. Differential activation of cytosolic phospholipase A2 (cPLA2) by thrombin and thrombin receptor agonist peptide in human platelets. J Biol Chem. 1995;270:14816-14823.